{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:02Z","timestamp":1786979762391,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00210-020-01979-y","type":"journal-article","created":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T20:02:33Z","timestamp":1601236953000},"page":"349-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII\/NF-\u03baB\/TGF-\u03b21 and PPAR-\u03b3 signaling pathway"],"prefix":"10.1007","volume":"394","author":[{"given":"Aya A.","family":"Gbr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-2558","authenticated-orcid":false,"given":"Nayira A.","family":"Abdel Baky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba S.","family":"Zaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,28]]},"reference":[{"key":"1979_CR1","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.biopha.2018.11.064","volume":"109","author":"EM Abdelsamia","year":"2019","unstructured":"Abdelsamia EM, Khaleel SA, Balah A, Baky NAA (2019) Curcumin augments the cardioprotective effect of metformin in an experimental model of type I diabetes mellitus; impact of Nrf2\/HO-1 and JAK\/STAT pathways. Biomed Pharmacother 109:2136\u20132144. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.064","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1979_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, Evans RM (2013) PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat Med 19(5):557\u2013566. https:\/\/doi.org\/10.1038\/nm.3159","journal-title":"Nat Med"},{"key":"1979_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejphar.2018.04.032","volume":"831","author":"RM Ali","year":"2018","unstructured":"Ali RM, Al-Shorbagy MY, Helmy MW, El-Abhar HS (2018) Role of Wnt4\/\u03b2-catenin, Ang II\/TGF\u03b2, ACE2, NF-\u03baB, and IL-18 in attenuating renal ischemia\/reperfusion-induced injury in rats treated with vit D and pioglitazone. Eur J Pharmacol 831:68\u201376. https:\/\/doi.org\/10.1016\/j.ejphar.2018.04.032","journal-title":"Eur J Pharmacol"},{"key":"1979_CR4","volume-title":"Theory and practice of histological techniques","author":"JD Banchroft","year":"1996","unstructured":"Banchroft JD, Stevens A, Turner D (1996) Theory and practice of histological techniques, 4th edn. Churchill Livingstone, New York","edition":"4"},{"issue":"4","key":"1979_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00395-018-0688-8","volume":"113","author":"J Beckendorf","year":"2018","unstructured":"Beckendorf J, van den Hoogenhof MM, Backs J (2018) Physiological and unappreciated roles of CaMKII in the heart. Basic Res Cardiol 113(4):29. https:\/\/doi.org\/10.1007\/s00395-018-0688-8","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"1979_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.diabres.2007.04.012","volume":"78","author":"R Bhat","year":"2007","unstructured":"Bhat R, Bhansali A, Bhadada S, Sialy R (2007) Effect of pioglitazone therapy in lean type1 diabetes mellitus. Diabetes Res Clin Pract 78(3):349\u2013354. https:\/\/doi.org\/10.1016\/j.diabres.2007.04.012","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1979_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina S, Abel ED (2010) Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11(1):31\u201339. https:\/\/doi.org\/10.1007\/s11154-010-9131-7","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"1979_CR8","doi-asserted-by":"publisher","first-page":"L1146","DOI":"10.1152\/ajplung.00383.2004","volume":"288","author":"HA Burgess","year":"2005","unstructured":"Burgess HA, Daugherty LE, Thatcher TH, Lakatos HF, Ray DM, Redonnet M, Sime PJ (2005) PPAR\u03b3 agonists inhibit TGF-\u03b2 induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol 288(6):L1146\u2013L1153. https:\/\/doi.org\/10.1152\/ajplung.00383.2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"1979_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s1097-2765(01)00164-2","volume":"7","author":"A Chawla","year":"2001","unstructured":"Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Evans RM (2001) A PPAR\u03b3-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7(1):161\u2013171. https:\/\/doi.org\/10.1016\/s1097-2765(01)00164-2","journal-title":"Mol Cell"},{"issue":"1","key":"1979_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.yexcr.2014.08.021","volume":"330","author":"XQ Chen","year":"2015","unstructured":"Chen XQ, Liu X, Wang QX, Zhang MJ, Guo M, Liu F, Zhou L (2015) Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-\u03baB\/TGF-\u03b21\/TRIF\/TRAF6 pathway. Exp Cell Res 330(1):43\u201355. https:\/\/doi.org\/10.1016\/j.yexcr.2014.08.021","journal-title":"Exp Cell Res"},{"issue":"8","key":"1979_CR11","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1111\/j.1476-5381.2010.00671.x","volume":"160","author":"M Collino","year":"2010","unstructured":"Collino M, Aragno M, Castiglia S, Miglio G, Tomasinelli C, Boccuzzi G, Fantozzi R (2010) Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. Br J Pharmacol 160(8):1892\u20131902. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00671.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1979_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1177\/0897190014549837","volume":"29","author":"M DeGeeter","year":"2014","unstructured":"DeGeeter M, Williamson B (2014) Alternative agents in type 1 diabetes in addition to insulin therapy: metformin, alpha-glucosidase inhibitors, pioglitazone, GLP-1 agonists, DPP-IV inhibitors, and SGLT-2 inhibitors. J Pharm Pract 29(2):144\u2013159. https:\/\/doi.org\/10.1177\/0897190014549837","journal-title":"J Pharm Pract"},{"issue":"4","key":"1979_CR13","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.3892\/mmr.2014.3113","volume":"11","author":"BB Di","year":"2014","unstructured":"Di BB, Li HW, Li WP, Shen XH, Sun ZJ, Wu X (2014) Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells. Mol Med Rep 11(4):2601\u20132607. https:\/\/doi.org\/10.3892\/mmr.2014.3113","journal-title":"Mol Med Rep"},{"key":"1979_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.taap.2018.10.022","volume":"362","author":"S Elshazly","year":"2019","unstructured":"Elshazly S, Soliman E (2019) PPAR gamma agonist, pioglitazone, rescues liver damage induced by renal ischemia\/reperfusion injury. Toxicol Appl Pharmacol 362:86\u201394. https:\/\/doi.org\/10.1016\/j.taap.2018.10.022","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"1979_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1152\/physrev.00018.2010","volume":"91","author":"JR Erickson","year":"2011","unstructured":"Erickson JR, He BJ, Grumbach IM, Anderson ME (2011) CaMKII in the cardiovascular system: sensing redox states. Physiol Rev 91(3):889\u2013915. https:\/\/doi.org\/10.1152\/physrev.00018.2010","journal-title":"Physiol Rev"},{"issue":"4","key":"1979_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1210\/er.2003-0012","volume":"25","author":"ZY Fang","year":"2004","unstructured":"Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25(4):543\u2013567. https:\/\/doi.org\/10.1210\/er.2003-0012","journal-title":"Endocr Rev"},{"issue":"23","key":"1979_CR17","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.2174\/1568026615666150619142519","volume":"15","author":"S Fazel Nabavi","year":"2015","unstructured":"Fazel Nabavi S, Thiagarajan R, Rastrelli L, Daglia M, Sobarzo-Sanchez E, Alinezhad H, Mohammad Nabavi S (2015) Curcumin: a natural product for diabetes and its complications. Curr Top Med Chem 15(23):2445\u20132455. https:\/\/doi.org\/10.2174\/1568026615666150619142519","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"1979_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/aps.2017.92","volume":"39","author":"S Guo","year":"2017","unstructured":"Guo S, Meng XW, Yang XS, Liu XF, Ou-Yang CH, Liu C (2017) Curcumin administration suppresses collagen synthesis in the hearts of rats with experimental diabetes. Acta Pharmacol Sin 39(2):195\u2013204. https:\/\/doi.org\/10.1038\/aps.2017.92","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"1979_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/157016106777698469","volume":"4","author":"MA Haidara","year":"2006","unstructured":"Haidara MA, Yassin HZ, Rateb M, Ammar H, Zorkani MA (2006) Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Curr Vasc Pharmacol 4(3):215\u2013227. https:\/\/doi.org\/10.2174\/157016106777698469","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"1979_CR20","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1210\/en.2013-1519","volume":"155","author":"T Hara","year":"2014","unstructured":"Hara T, Mahadevan J, Kanekura K, Hara M, Lu S, Urano F (2014) Calcium efflux from the endoplasmic reticulum leads to \u03b2-cell death. Endocrinology. 155(3):758\u2013768. https:\/\/doi.org\/10.1210\/en.2013-1519","journal-title":"Endocrinology."},{"key":"1979_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.yjmcc.2019.01.001","volume":"127","author":"B Hegyi","year":"2019","unstructured":"Hegyi B, Bers DM, Bossuyt J (2019) CaMKII signaling in heart diseases: emerging role in diabetic cardiomyopathy. J Mol Cell Cardiol 127:246\u2013259. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.01.001","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"1979_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/SHK.0000000000000051","volume":"41","author":"MJ Hobson","year":"2014","unstructured":"Hobson MJ, Hake PW, O\u2019Connor M, Schulte C, Moore V, James JM, Zingarelli B (2014) Conditional deletion of cardiomyocyte peroxisome proliferator-activated receptor-\u03b3 enhances myocardial ischemia-reperfusion injury in mice. Shock. 41(1):40\u201347. https:\/\/doi.org\/10.1097\/SHK.0000000000000051","journal-title":"Shock."},{"issue":"2","key":"1979_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/08923973.2014.884135","volume":"36","author":"MA Ibrahim","year":"2014","unstructured":"Ibrahim MA, El-Sheikh AA, Khalaf HM, Abdelrahman AM (2014) Protective effect of peroxisome proliferator activator receptor (PPAR)-\u03b1 and-\u03b3 ligands against methotrexate-induced nephrotoxicity. Immunopharmacol Immunotoxicol 36(2):130\u2013137. https:\/\/doi.org\/10.3109\/08923973.2014.884135","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1979_CR24","doi-asserted-by":"crossref","unstructured":"Javeri I, Chand N (2016) Curcumin. In: Nutraceuticals. Academic Press, pp 435\u2013445","DOI":"10.1016\/B978-0-12-802147-7.00031-0"},{"issue":"4","key":"1979_CR25","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR (2018) Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res 122(4):624\u2013638. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311586","journal-title":"Circ Res"},{"issue":"1\u20133","key":"1979_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejphar.2013.03.047","volume":"710","author":"K Kistam\u00e1s","year":"2013","unstructured":"Kistam\u00e1s K, Szentandr\u00e1ssy N, Hegyi B, Ruzsnavszky F, V\u00e1czi K, B\u00e1r\u00e1ndi L, Kecskem\u00e9ti V (2013) Effects of pioglitazone on cardiac ion currents and action potential morphology in canine ventricular myocytes. Eur J Pharmacol 710(1\u20133):10\u201319. https:\/\/doi.org\/10.1016\/j.ejphar.2013.03.047","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"1979_CR27","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1080\/10408398.2015.1077195","volume":"57","author":"B Kocaadam","year":"2017","unstructured":"Kocaadam B, \u015eanlier N (2017) Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr 57(13):2889\u20132895. https:\/\/doi.org\/10.1080\/10408398.2015.1077195","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"1979_CR28","doi-asserted-by":"publisher","first-page":"e115947","DOI":"10.1371\/journal.pone.0115947","volume":"10","author":"D Kumar","year":"2015","unstructured":"Kumar D, Singla SK, Puri V, Puri S (2015) The restrained expression of NF-kB in renal tissue ameliorates folic acid induced acute kidney injury in mice. PLoS One 10(1):e115947. https:\/\/doi.org\/10.1371\/journal.pone.0115947","journal-title":"PLoS One"},{"issue":"2","key":"1979_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1530\/JME-14-0063","volume":"53","author":"M Kurtz","year":"2014","unstructured":"Kurtz M, Capobianco E, Martinez N, Roberti SL, Arany E, Jawerbaum A (2014) PPAR ligands improve impaired metabolic pathways in fetal hearts of diabetic rats. J Mol Endocrinol 53(2):237\u2013246. https:\/\/doi.org\/10.1530\/JME-14-0063","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"1979_CR30","first-page":"225","volume":"117","author":"YANG Lan","year":"2004","unstructured":"Lan YANG, Zhou Q, Wu ZL (2004) NF-kappa B involved in transcription enhancement of TGF-beta 1 induced by Ox-LDL in rat mesangial cells. Chin Med J 117(2):225\u2013230","journal-title":"Chin Med J"},{"issue":"3","key":"1979_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.diabres.2013.01.008","volume":"100","author":"TI Lee","year":"2013","unstructured":"Lee TI, Kao YH, Chen YC, Huang JH, Hsiao FC, Chen YJ (2013) Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy. Diabetes Res Clin Pract 100(3):330\u2013339. https:\/\/doi.org\/10.1016\/j.diabres.2013.01.008","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"1979_CR32","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1074\/jbc.M511153200","volume":"281","author":"Q Li","year":"2006","unstructured":"Li Q, Engelhardt JF (2006) Interleukin-1\u03b2 induction of NF\u03baB is partially regulated by H2O2-mediated activation of NF\u03baB-inducing kinase. J Biol Chem 281(3):1495\u20131505. https:\/\/doi.org\/10.1074\/jbc.M511153200","journal-title":"J Biol Chem"},{"issue":"3","key":"1979_CR33","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1159\/000447826","volume":"39","author":"J Li","year":"2016","unstructured":"Li J, Wang P, Ying J, Chen Z, Yu S (2016) Curcumin attenuates retinal vascular leakage by inhibiting calcium\/calmodulin-dependent protein kinase II activity in streptozotocin-induced diabetes. Cell Physiol Biochem 39(3):1196\u20131208. https:\/\/doi.org\/10.1159\/000447826","journal-title":"Cell Physiol Biochem"},{"issue":"13","key":"1979_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9086747","volume":"9086747","author":"E Liang","year":"2018","unstructured":"Liang E, Liu X, Du Z, Yang R, Zhao Y (2018) Andrographolide ameliorates diabetic cardiomyopathy in mice by blockage of oxidative damage and NF-\u03baB-mediated inflammation. Oxidative Med Cell Longev 9086747(13):1\u201313. https:\/\/doi.org\/10.1155\/2018\/9086747","journal-title":"Oxidative Med Cell Longev"},{"key":"1979_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","volume":"7","author":"K Lingappan","year":"2018","unstructured":"Lingappan K (2018) NF-\u03baB in oxidative stress. Curr Opin Toxicol 7:81\u201386. https:\/\/doi.org\/10.1016\/j.cotox.2017.11.002","journal-title":"Curr Opin Toxicol"},{"issue":"1","key":"1979_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2009.09.026","volume":"48","author":"RM Liu","year":"2010","unstructured":"Liu RM, Pravia KG (2010) Oxidative stress and glutathione in TGF-\u03b2-mediated fibrogenesis. Free Radic Biol Med 48(1):1\u201315. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.09.026","journal-title":"Free Radic Biol Med"},{"key":"1979_CR37","doi-asserted-by":"publisher","unstructured":"Liu HJ, Liao HH, Yang Z, Tang QZ (2016) Peroxisome proliferator-activated receptor-\u03b3 is critical to cardiac fibrosis. PPAR Res 2016. https:\/\/doi.org\/10.1155\/2016\/2198645","DOI":"10.1155\/2016\/2198645"},{"issue":"3","key":"1979_CR38","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1172\/JCI65268","volume":"123","author":"M Luo","year":"2013","unstructured":"Luo M, Guan X, Luczak ED, Lang D, Kutschke W, Gao Z, Weiss RM (2013) Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. J Clin Invest 123(3):1262\u20131274. https:\/\/doi.org\/10.1172\/JCI65268","journal-title":"J Clin Invest"},{"issue":"2","key":"1979_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00424-013-1326-9","volume":"466","author":"TP Martin","year":"2013","unstructured":"Martin TP, Lawan A, Robinson E, Grieve DJ, Plevin R, Paul A, Currie S (2013) Adult cardiac fibroblast proliferation is modulated by calcium\/calmodulin-dependent protein kinase II in normal and hypertrophied hearts. Pflugers Arch 466(2):319\u2013330. https:\/\/doi.org\/10.1007\/s00424-013-1326-9","journal-title":"Pflugers Arch"},{"issue":"6","key":"1979_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY (2016) TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol 12(6):325\u2013338. https:\/\/doi.org\/10.1038\/nrneph.2016.48","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"1979_CR41","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2337\/diacare.25.3.517","volume":"25","author":"Y Miyazaki","year":"2002","unstructured":"Miyazaki Y, Matsuda M, DeFronzo RA (2002) Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes. Diabetes Care 25(3):517\u2013523. https:\/\/doi.org\/10.2337\/diacare.25.3.517","journal-title":"Diabetes Care"},{"key":"1979_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10557-020-06968-0","volume":"34","author":"T Ni","year":"2020","unstructured":"Ni T, Lin N, Lu W, Sun Z, Lin H, Chi J, Guo H (2020) Dihydromyricetin prevents diabetic cardiomyopathy via miR-34a suppression by activating autophagy. Cardiovasc Drugs Ther 34:1\u201311. https:\/\/doi.org\/10.1007\/s10557-020-06968-0","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"1979_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/01.ATV.0000112930.40564.89","volume":"24","author":"T Omura","year":"2004","unstructured":"Omura T, Yoshiyama M, Kim S, Matsumoto R, Nakamura Y, Izumi Y, Takeuchi K (2004) Involvement of apoptosis signal-regulating kinase-1 on angiotensin II-induced monocyte chemoattractant protein-1 expression. J Cardiovasc Pharmacol 24(2):270\u2013275. https:\/\/doi.org\/10.1161\/01.ATV.0000112930.40564.89","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"1979_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/ki.2012.439","volume":"83","author":"S Ruiz","year":"2013","unstructured":"Ruiz S, Pergola PE, Zager RA, Vaziri ND (2013) Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int 83(6):1029\u20131041. https:\/\/doi.org\/10.1038\/ki.2012.439","journal-title":"Kidney Int"},{"issue":"18","key":"1979_CR45","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.3390\/ijms20184374","volume":"20","author":"MR Rusciano","year":"2019","unstructured":"Rusciano MR, Sommariva E, Douin-Echinard V, Ciccarelli M, Poggio P, Maione AS (2019) CaMKII activity in the inflammatory response of cardiac diseases. Int J Mol Sci 20(18):4374. https:\/\/doi.org\/10.3390\/ijms20184374","journal-title":"Int J Mol Sci"},{"key":"1979_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","volume":"90","author":"I Russo","year":"2015","unstructured":"Russo I, Frangogiannis NG (2015) Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol 90:84\u201393. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.12.011","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"1979_CR47","first-page":"10.33549\/physio","volume":"67","author":"KA Salem","year":"2018","unstructured":"Salem KA, Sydorenko V, Qureshi M, Oz M, Howarth FC (2018) Effects of pioglitazone on ventricular myocyte shortening and Ca 2+ transport in the Goto-Kakizaki type 2 diabetic rat. Physiol Res 67(1):10.33549\/physiolres.933567","journal-title":"Physiol Res"},{"issue":"27","key":"1979_CR48","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","volume":"36","author":"PM Seferovi\u0107","year":"2015","unstructured":"Seferovi\u0107 PM, Paulus WJ (2015) Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J 36(27):1718\u20131727. https:\/\/doi.org\/10.1093\/eurheartj\/ehv134","journal-title":"Eur Heart J"},{"issue":"4","key":"1979_CR49","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s00380-013-0402-6","volume":"29","author":"T Shida","year":"2014","unstructured":"Shida T, Nozawa T, Sobajima M, Ihori H, Matsuki A, Inoue H (2014) Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature. Heart Vessel 29(4):532\u2013541. https:\/\/doi.org\/10.1007\/s00380-013-0402-6","journal-title":"Heart Vessel"},{"issue":"4","key":"1979_CR50","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1172\/JCI35814","volume":"119","author":"MV Singh","year":"2009","unstructured":"Singh MV, Kapoun A, Higgins L, Kutschke W, Thurman JM, Zhang R, Weiss RM (2009) Ca 2+\/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart. J Clin Invest 119(4):986\u2013996. https:\/\/doi.org\/10.1172\/JCI35814","journal-title":"J Clin Invest"},{"issue":"3","key":"1979_CR51","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ejps.2012.04.018","volume":"47","author":"V Soetikno","year":"2012","unstructured":"Soetikno V, Sari FR, Sukumaran V, Lakshmanan AP, Mito S, Harima M, Watanabe K (2012) Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC\u2013MAPK signaling pathway. Eur J Pharm Sci 47(3):604\u2013614. https:\/\/doi.org\/10.1016\/j.ejps.2012.04.018","journal-title":"Eur J Pharm Sci"},{"key":"1979_CR52","doi-asserted-by":"publisher","first-page":"117047","DOI":"10.1016\/j.lfs.2019.117047","volume":"239","author":"E Soliman","year":"2019","unstructured":"Soliman E, Behairy SF, El-maraghy NN, Elshazly SM (2019) PPAR-\u03b3 agonist, pioglitazone, reduced oxidative and endoplasmic reticulum stress associated with L-NAME-induced hypertension in rats. Life Sci 239:117047. https:\/\/doi.org\/10.1016\/j.lfs.2019.117047","journal-title":"Life Sci"},{"issue":"22","key":"1979_CR53","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1161\/CIRCULATIONAHA.118.034621","volume":"138","author":"T Suetomi","year":"2018","unstructured":"Suetomi T, Willeford A, Brand CS, Cho Y, Ross RS, Miyamoto S, Brown JH (2018) Inflammation and NLRP3 inflammasome activation initiated in response to pressure overload by Ca2+\/Calmodulin-dependent protein kinase II \u03b4 signaling in cardiomyocytes are essential for adverse cardiac remodeling. Circulation. 138(22):2530\u20132544. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034621","journal-title":"Circulation."},{"issue":"3","key":"1979_CR54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1440-1797.2007.00796.x","volume":"12","author":"GH Tesch","year":"2007","unstructured":"Tesch GH, Allen TJ (2007) Rodent models of streptozotocin-induced diabetic nephropathy (methods in renal research). Nephrology (Carlton) 12(3):261\u2013266. https:\/\/doi.org\/10.1111\/j.1440-1797.2007.00796.x","journal-title":"Nephrology (Carlton)"},{"issue":"01","key":"1979_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-0043-106859","volume":"126","author":"MAE Wassef","year":"2018","unstructured":"Wassef MAE, Tork OM, Rashed LA, Ibrahim W, Morsi H, Rabie DMM (2018) Mitochondrial dysfunction in diabetic cardiomyopathy: effect of mesenchymal stem cell with ppar-\u03b3 agonist or exendin-4. Exp Clin Endocrinol Diabetes 126(01):27\u201338. https:\/\/doi.org\/10.1055\/s-0043-106859","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"1979_CR56","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/BOR.0b013e32833de1a7","volume":"22","author":"J Wei","year":"2010","unstructured":"Wei J, Bhattacharyya S, Varga J (2010) Peroxisome proliferator-activated receptor \u03b3: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis. Curr Opin Rheumatol 22(6):671\u2013676. https:\/\/doi.org\/10.1097\/BOR.0b013e32833de1a7","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"1979_CR57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3892\/mmr.2017.7911","volume":"17","author":"Z Xie","year":"2018","unstructured":"Xie Z, Wu B, Shen G, Li X, Wu Q (2018) Curcumin alleviates liver oxidative stress in type 1 diabetic rats. Mol Med Rep 17(1):103\u2013108. https:\/\/doi.org\/10.3892\/mmr.2017.7911","journal-title":"Mol Med Rep"},{"key":"1979_CR58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.yjmcc.2018.10.004","volume":"124","author":"Q Yao","year":"2018","unstructured":"Yao Q, Ke ZQ, Guo S, Yang XS, Zhang FX, Liu XF, Liu C (2018) Curcumin protects against diabetic cardiomyopathy by promoting autophagy and alleviating apoptosis. J Mol Cell Cardiol 124:26\u201334. https:\/\/doi.org\/10.1016\/j.yjmcc.2018.10.004","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"1979_CR59","doi-asserted-by":"publisher","first-page":"e52013","DOI":"10.1371\/journal.pone.0052013","volume":"7","author":"W Yu","year":"2012","unstructured":"Yu W, Wu J, Cai F, Xiang J, Zha W, Fan D, Liu C (2012) Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. PLoS One 7(12):e52013. https:\/\/doi.org\/10.1371\/journal.pone.0052013","journal-title":"PLoS One"},{"issue":"4","key":"1979_CR60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s40618-013-0046-5","volume":"37","author":"M Yuan","year":"2014","unstructured":"Yuan M, Qiu M, Cui J, Zhang X, Zhang P (2014) Protective effects of pioglitazone against immunoglobulin deposition on heart of streptozotocin-induced diabetic rats. J Endocrinol Investig 37(4):375\u2013384. https:\/\/doi.org\/10.1007\/s40618-013-0046-5","journal-title":"J Endocrinol Investig"},{"key":"1979_CR61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","volume":"133","author":"Y Yue","year":"2017","unstructured":"Yue Y, Meng K, Pu Y, Zhang X (2017) Transforming growth factor beta (TGF-\u03b2) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract 133:124\u2013130. https:\/\/doi.org\/10.1016\/j.diabres.2017.08.018","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1979_CR62","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/FJC.0b013e3181c9548b","volume":"55","author":"W Zhang","year":"2010","unstructured":"Zhang W, Chen DQ, Qi F, Wang J, Xiao WY, Zhu WZ (2010) Inhibition of calcium\u2013calmodulin-dependent kinase II suppresses cardiac fibroblast proliferation and extracellular matrix secretion. J Cardiovasc Pharmacol 55(1):96\u2013105. https:\/\/doi.org\/10.1097\/FJC.0b013e3181c9548b","journal-title":"J Cardiovasc Pharmacol"},{"key":"1979_CR63","doi-asserted-by":"publisher","unstructured":"Zhang B, Zhai M, Li B, Liu Z, Li K, Jiang L, Liang H (2018, 2018) Honokiol ameliorates myocardial ischemia\/reperfusion injury in type 1 diabetic rats by reducing oxidative stress and apoptosis through activating the SIRT1-Nrf2 signaling pathway. Oxidative Med Cell Longev. https:\/\/doi.org\/10.1155\/2018\/3159801","DOI":"10.1155\/2018\/3159801"},{"issue":"1","key":"1979_CR64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/1074248417707049","volume":"23","author":"CB Zhong","year":"2018","unstructured":"Zhong CB, Chen X, Zhou XY, Wang XB (2018) The role of peroxisome proliferator-activated receptor \u03b3 in mediating cardioprotection against ischemia\/reperfusion injury. J Cardiovasc Pharmacol Ther 23(1):46\u201356. https:\/\/doi.org\/10.1177\/1074248417707049","journal-title":"J Cardiovasc Pharmacol Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01979-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-020-01979-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01979-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T21:13:12Z","timestamp":1632777192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-020-01979-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,28]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1979"],"URL":"https:\/\/doi.org\/10.1007\/s00210-020-01979-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,28]]},"assertion":[{"value":"10 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal experiments were approved by Animal Ethics Committee of the Faculty of Pharmacy, Al-Azhar University, Egypt (approval number: 79\/2016).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}